Literature DB >> 12403067

Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.

Antonio Quintana1, Ewa Raczka, Lars Piehler, Inhan Lee, Andrzej Myc, Istvan Majoros, Anil K Patri, Thommey Thomas, James Mulé, James R Baker.   

Abstract

PURPOSE: We sought to develop nanoscale drug delivery material that would allow targeted intracellular delivery while having an imaging capability for tracking uptake of the material. A complex nanodevice was designed and synthesized that targets tumor cell through the folate receptor.
METHODS: The device is based on an ethylenediamine core polyamidoamine dendrimer of generation 5. Folic acid, fluorescein, and methotrexate were covalently attached to the surface to provide targeting, imaging, and intracellular drug delivery capabilities. Molecular modeling determined the optimal dendrimer surface modification for the function of the device and suggested a surface modification that improved targeting.
RESULTS: Three nanodevices were synthesized. Experimental targeting data in KB cells confirmed the modeling predictions of specific and highly selective binding. Targeted delivery improved the cytotoxic response of the cells to methotrexate 100-fold over free drug.
CONCLUSIONS: These results demonstrate the ability to design and produce polymer-based nanodevices for the intracellular targeting of drugs, imaging agents, and other materials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403067     DOI: 10.1023/a:1020398624602

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Detection of chemoresistance profile of cell lines K562, KB, GLC4 and HL60 through characterisation of the hmdr1, mrp and lrp transcripts.

Authors:  A S Gauchez; J Lunardi; C Pernin; D Marti-Battle; D Fagret
Journal:  In Vivo       Date:  2001 Jan-Feb       Impact factor: 2.155

2.  Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.

Authors:  S Wang; R J Lee; C J Mathias; M A Green; P S Low
Journal:  Bioconjug Chem       Date:  1996 Jan-Feb       Impact factor: 4.774

3.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Authors:  N Malik; R Wiwattanapatapee; R Klopsch; K Lorenz; H Frey; J W Weener; E W Meijer; W Paulus; R Duncan
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

4.  Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.

Authors:  A Bielinska; J F Kukowska-Latallo; J Johnson; D A Tomalia; J R Baker
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

5.  Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers.

Authors:  J F Kukowska-Latallo; A U Bielinska; J Johnson; R Spindler; D A Tomalia; J R Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

6.  Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells.

Authors:  A C Antony; M A Kane; R M Portillo; P C Elwood; J F Kolhouse
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

7.  Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.

Authors:  S Wang; R J Lee; G Cauchon; D G Gorenstein; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications.

Authors:  J F Ross; P K Chaudhuri; M Ratnam
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

9.  Selective targeting of malignant cells with cytotoxin-folate conjugates.

Authors:  C P Leamon; P S Low
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

10.  Properties of a folate binding protein (FBP) isolated from porcine kidney.

Authors:  B A Kamen; J D Caston
Journal:  Biochem Pharmacol       Date:  1986-07-15       Impact factor: 5.858

View more
  100 in total

1.  Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations.

Authors:  Shihu Wang; Elena E Dormidontova
Journal:  Biomacromolecules       Date:  2010-07-12       Impact factor: 6.988

2.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

Review 3.  Biologically optimized nanosized molecules and particles: more than just size.

Authors:  Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2011-05-11       Impact factor: 4.774

4.  Medicine on a small scale.

Authors:  Marijeta Kralj; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2003-11       Impact factor: 8.807

Review 5.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

6.  Electrophoretic Behavior of Anionic Triazine and PAMAM Dendrimers: Methods for Improving Resolution and Assessing Purity Using Capillary Electrophoresis.

Authors:  Sanjiv Lalwani; Vincent J Venditto; Abdellatif Chouai; Gregory E Rivera; Sunil Shaunak; Eric E Simanek
Journal:  Macromolecules       Date:  2009-04-28       Impact factor: 5.985

Review 7.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

8.  N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers.

Authors:  Scott H Medina; Venkatesh Tekumalla; Maxim V Chevliakov; Donna S Shewach; William D Ensminger; Mohamed E H El-Sayed
Journal:  Biomaterials       Date:  2011-03-22       Impact factor: 12.479

9.  Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications.

Authors:  Mohiuddin A Quadir; Stephen W Morton; Lawrence B Mensah; Kevin Shopsowitz; Jeroen Dobbelaar; Nicole Effenberger; Paula T Hammond
Journal:  Nanomedicine       Date:  2017-03-02       Impact factor: 5.307

10.  Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.

Authors:  Andrzej Myc; Jolanta Kukowska-Latallo; Peter Cao; Ben Swanson; Julianna Battista; Thomas Dunham; James R Baker
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.